May 21, 2024, 15:48
Cancer Network – A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X:
“So much fun speaking with Saad Z. Usmani, Yi Lin, Doris Hansen about CAR-T in MMsm – and the ‘CAR-eligible’ vs ineligible pathways of the future. Although if our shirt colors are any indicator, for an RCT of CAR-T vs ‘investigator’s choice’ we’d all choose the same thing. ”
Quoting Cancer Network‘s post:
“A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy, highlighting BCMA as a target and treatment administration practices.”
Source: Rahul Banerjee/X and Cancer Network/X